These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 29758794)
1. Interview: A perspective on personalized medicine: Dr David Korn. Korn D Per Med; 2012 May; 9(3):259-263. PubMed ID: 29758794 [TBL] [Abstract][Full Text] [Related]
2. Interview: An evolving career in personalized medicine: an interview with Dr Paul Billings. Billings P Per Med; 2012 May; 9(3):253-257. PubMed ID: 29758789 [TBL] [Abstract][Full Text] [Related]
3. The JIM interview. David Korn, MD. Korn D J Investig Med; 1995 Apr; 43(2):108-15. PubMed ID: 7735914 [TBL] [Abstract][Full Text] [Related]
4. Advancing treatment of metastatic cancers: from research to communication--where do we need to go? Zetter B; Lake F Future Oncol; 2014; 10(9):1535-40. PubMed ID: 25145423 [TBL] [Abstract][Full Text] [Related]
6. Leading the way in biomedical engineering: an interview with Robert Langer. Interview by Hannah Stanwix, Commissioning Editor. Langer R Nanomedicine (Lond); 2012 Oct; 7(10):1483-4. PubMed ID: 23148539 [TBL] [Abstract][Full Text] [Related]
7. Women's health research in the last four decades. Interview by Natasha Leeson. Weiss G Womens Health (Lond); 2014 Jan; 10(1):13-6. PubMed ID: 24328595 [TBL] [Abstract][Full Text] [Related]
8. Stuart Schreiber: biology from a chemist's perspective. Interview by Joanna Owens. Schreiber SL Drug Discov Today; 2004 Apr; 9(7):299-303. PubMed ID: 15037226 [TBL] [Abstract][Full Text] [Related]
9. Interview with James Bradner. Interviewed by Hannah Coaker. Bradner JE Future Med Chem; 2013 Aug; 5(12):1373-6. PubMed ID: 23919548 [TBL] [Abstract][Full Text] [Related]
10. Interview: commercial translation of cell-based therapies and regenerative medicine: learning by experience. Interview by Emily Culme-Seymour. Haseltine WA Regen Med; 2011 Jul; 6(4):431-5. PubMed ID: 21749201 [TBL] [Abstract][Full Text] [Related]
11. Drug delivery, biomaterials and nanomedicine: an interview with Daniel S Kohane. Kohane DS Future Sci OA; 2016 Sep; 2(3):FSO138. PubMed ID: 28031981 [No Abstract] [Full Text] [Related]
12. Research and development in the molecular genetics of pituitary adenomas and related tumors. Stratakis CA Expert Rev Endocrinol Metab; 2012 Nov; 7(6):593-598. PubMed ID: 30754126 [TBL] [Abstract][Full Text] [Related]
13. Utilizing biomarkers in colorectal cancer: an interview with Ajay Goel. Goel A Future Oncol; 2017 Dec; 13(28):2511-2514. PubMed ID: 29168653 [TBL] [Abstract][Full Text] [Related]
14. Interview: A private sector life in comparative effectiveness research. Interview with Robert W Dubois. Dubois RW J Comp Eff Res; 2013 Sep; 2(5):429-31. PubMed ID: 24236739 [TBL] [Abstract][Full Text] [Related]
15. Interview with Loren D Walensky. Walensky LD Future Med Chem; 2012 Aug; 4(12):1537-9. PubMed ID: 22917243 [TBL] [Abstract][Full Text] [Related]
16. Genomics and personalized medicine: a perspective. Desnick RJ Per Med; 2009 Mar; 6(2):135-137. PubMed ID: 29788601 [TBL] [Abstract][Full Text] [Related]
17. Transitioning biomarkers into the clinic. Waldman SA Expert Rev Clin Pharmacol; 2009 Jan; 2(1):9-13. PubMed ID: 24422768 [TBL] [Abstract][Full Text] [Related]
18. An interview with Professor Robert J. Lefkowitz, M.D. Interview by Vicki Glaser. Lefkowitz RJ Assay Drug Dev Technol; 2003 Apr; 1(2):233-8. PubMed ID: 15090188 [TBL] [Abstract][Full Text] [Related]
19. The challenges and future of oral drug delivery: An interview with David Brayden. Brayden DJ Ther Deliv; 2016 Dec; 7(12):791-794. PubMed ID: 27824287 [TBL] [Abstract][Full Text] [Related]
20. Investigator profile. An interview with Keith Cheng, M.D., Ph.D. Interview by Vicki Glaser. Glaser V Zebrafish; 2006; 3(1):1-7. PubMed ID: 18248241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]